DE1810423C3 - - Google Patents

Info

Publication number
DE1810423C3
DE1810423C3 DE1810423A DE1810423A DE1810423C3 DE 1810423 C3 DE1810423 C3 DE 1810423C3 DE 1810423 A DE1810423 A DE 1810423A DE 1810423 A DE1810423 A DE 1810423A DE 1810423 C3 DE1810423 C3 DE 1810423C3
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1810423A
Other languages
German (de)
Other versions
DE1810423A1 (de
DE1810423B2 (de
Inventor
Karl-Heinz Dr. 6535 Gaualgesheim Weber
Karl Prof.Dr. Zeile
Peter Dr. Danneberg
Rolf Dr. 6530 Bingen Giesemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of DE1810423A1 publication Critical patent/DE1810423A1/de
Publication of DE1810423B2 publication Critical patent/DE1810423B2/de
Application granted granted Critical
Publication of DE1810423C3 publication Critical patent/DE1810423C3/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19681810423 1967-11-24 1968-11-22 1-phenyl-4-alkyl-1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-dionderivate Granted DE1810423B2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1064767A AT280290B (de) 1967-11-24 1967-11-24 Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen

Publications (3)

Publication Number Publication Date
DE1810423A1 DE1810423A1 (de) 1969-10-09
DE1810423B2 DE1810423B2 (de) 1973-03-22
DE1810423C3 true DE1810423C3 (enExample) 1973-10-11

Family

ID=3623762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681810423 Granted DE1810423B2 (de) 1967-11-24 1968-11-22 1-phenyl-4-alkyl-1,2,4,5-tetrahydro-3h-1,4-benzodiazepin-2,5-dionderivate

Country Status (13)

Country Link
AT (1) AT280290B (enExample)
BE (1) BE724364A (enExample)
BR (1) BR6804236D0 (enExample)
CH (1) CH523265A (enExample)
DE (1) DE1810423B2 (enExample)
DK (1) DK124950B (enExample)
ES (2) ES360410A1 (enExample)
FR (2) FR1593335A (enExample)
GB (1) GB1173540A (enExample)
IE (1) IE32504B1 (enExample)
IL (1) IL31146A (enExample)
NL (1) NL6815755A (enExample)
SE (1) SE356979B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497307B2 (en) 2008-09-11 2013-07-30 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8815845B2 (en) 2009-11-17 2014-08-26 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
US9126978B2 (en) 2009-11-17 2015-09-08 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914216A (en) * 1962-12-18 1975-10-21 Boehringer Sohn Ingelheim 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
DE2117438A1 (de) * 1971-04-08 1972-10-19 CH. Boehringer Sohn, 6507 Ingelheim Neue substituiert 1,3-Dihydro-2H-1 ^-benzodiazepine^-one
BE793460A (fr) * 1971-12-29 1973-06-28 Boehringer Sohn Ingelheim Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h
WO2000066106A2 (en) 1999-04-30 2000-11-09 The Regents Of The University Of Michigan Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
US7144880B2 (en) 1999-04-30 2006-12-05 Regents Of The University Of Michigan Compositions relating to novel compounds and targets thereof
US7276348B2 (en) 1999-04-30 2007-10-02 Regents Of The University Of Michigan Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US7691582B2 (en) 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
WO2006074358A1 (en) 2005-01-03 2006-07-13 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
WO2007053193A2 (en) 2005-06-01 2007-05-10 The Regents Of The University Of Michigan Unsolvated benzodiazepine compositions and methods
AU2006308655B2 (en) 2005-11-01 2010-09-23 The Regents Of The University Of Michigan Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
CA2659549C (en) 2006-06-09 2013-07-30 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
CA2783589A1 (en) 2007-03-09 2008-09-18 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
EP2146722A4 (en) * 2007-05-10 2011-08-03 Amr Technology Inc ARYL AND HETEROARYL SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND THEIR USE FOR BLOCKING THE RECOVERY OF NOREPINEPHRIN, DOPAMINE AND SEROTONINE
ES2614498T3 (es) 2007-09-14 2017-05-31 The Regents Of The University Of Michigan Inhibidores de ATPasa F1F0 y métodos relacionados
UA99839C2 (ru) 2007-11-06 2012-10-10 Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган Бензодиазепиноновые соединения, применяемые при лечении кожных состояний
WO2010121164A2 (en) 2009-04-17 2010-10-21 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
EP2470020A4 (en) 2009-09-18 2013-03-13 Univ Michigan BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH
US11465978B2 (en) 2013-09-11 2022-10-11 The Administrators Of The Tulane Educational Fund Anthranilic amides and the use thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8497307B2 (en) 2008-09-11 2013-07-30 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8815845B2 (en) 2009-11-17 2014-08-26 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
US9126978B2 (en) 2009-11-17 2015-09-08 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties

Also Published As

Publication number Publication date
DK124950B (da) 1972-12-11
SE356979B (enExample) 1973-06-12
BE724364A (enExample) 1969-05-22
FR1593335A (enExample) 1970-05-25
DE1810423A1 (de) 1969-10-09
BR6804236D0 (pt) 1973-02-08
FR8310M (enExample) 1970-11-23
IL31146A (en) 1972-04-27
AT280290B (de) 1970-04-10
CH523265A (de) 1972-05-31
NL6815755A (enExample) 1969-05-28
GB1173540A (en) 1969-12-10
IE32504B1 (en) 1973-08-22
ES378977A1 (es) 1973-01-16
IE32504L (en) 1969-05-24
ES360410A1 (es) 1970-11-01
IL31146A0 (en) 1969-01-29
DE1810423B2 (de) 1973-03-22

Similar Documents

Publication Publication Date Title
AU425114B2 (enExample)
DE1810423C3 (enExample)
AU416737B2 (enExample)
AU2277767A (enExample)
AU342066A (enExample)
AU2528767A (enExample)
AU2977667A (enExample)
AU3151267A (enExample)
AU2454867A (enExample)
AU610966A (enExample)
AU2256867A (enExample)
AU2116667A (enExample)
BE710545A (enExample)
BE705293A (enExample)
BE692779A (enExample)
BE711239A (enExample)
BE710761A (enExample)
AU459699A (enExample)
BE162295A (enExample)
AU1868267A (enExample)
BE710388A (enExample)
BE426053A (enExample)
BE710214A (enExample)
AU408412B2 (enExample)
AU34866A (enExample)

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
E77 Valid patent as to the heymanns-index 1977
EHJ Ceased/non-payment of the annual fee